Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial. - Wikidata - awgldk - TriplyDB

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial.

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial.

http://www.wikidata.org/entity/Q39510239

about

Desipramine for neuropathic pain in adults Antidepressants for neuropathic pain Antidepressants for neuropathic pain Active placebos versus antidepressants for depression Animal models of peripheral neuropathies Antidepressants as analgesics: a review of randomized controlled trials Evidence-based data from animal and human experimental studies on pain relief with antidepressants: a structured review.Treating Diabetic Neuropathy: Present Strategies and Emerging Solutions.Painful diabetic neuropathy.Tricyclic antidepressant use in diabetic neuropathy.Clinical experience with desvenlafaxine in treatment of pain associated with diabetic peripheral neuropathy Management of the adverse effects of antiretroviral therapy and medication adherence.Antidepressants in the treatment of neuropathic pain.Treatment of painful diabetic neuropathy Burning through the pain: treatments for diabetic neuropathy.Neuropathic pain: evidence matters.EFNS guidelines on pharmacological treatment of neuropathic pain.Gabapentin versus tricyclic antidepressants for diabetic neuropathy and post-herpetic neuralgia: discrepancies between direct and indirect meta-analyses of randomized controlled trials Antidepressants inhibit P2X4 receptor function: a possible involvement in neuropathic pain relief Pharmacological treatment of diabetic peripheral neuropathy.Pharmacological strategies in relieving neuropathic pain.Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study.RGS9-2--controlled adaptations in the striatum determine the onset of action and efficacy of antidepressants in neuropathic pain states.Antinociceptive potentiation of pethidine (demerol) by clomipramine in the late phase of formalin test in mice Reward-aversion circuitry in analgesia and pain: implications for psychiatric disorders.Nociceptive and neuropathic pain in patients with lung cancer: a comparison of pain quality descriptors Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options.A combined effect of dextromethorphan and melatonin on neuropathic pain behavior in rats.Memantine (Namenda) for neuropathic pain.Identification of genes and signaling pathways associated with diabetic neuropathy using a weighted correlation network analysis: A consort study.Pain associated with diabetic peripheral neuropathy: a review of available treatments Sodium channel blockers for the treatment of neuropathic pain.Duloxetine in the long-term management of diabetic peripheral neuropathic pain: An open-label, 52-week extension of a randomized controlled clinical trial.Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain.Efficacy of antidepressants as analgesics: a review.Pharmacological treatment of diabetic neuropathic pain.Clinical Approach to the Treatment of Painful Diabetic Neuropathy.Management of painful diabetic neuropathy: guideline guidance or jungle?Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy.Diabetic neuropathy and oxidative stress: therapeutic perspectives.

P2860

Q24193468-4CB2D631-0D37-4974-9659-ED7BAB1CA9DA Q24243292-51616986-0E13-44AA-91AF-5A775E43EFC9 Q24246575-9F1AB2C8-2940-4CB1-95C5-91C9388345F3 Q24247474-D499FC1D-FA06-40C5-9409-F4A04B659937 Q27028046-2A55F8A0-567E-4615-BA3A-2B2D4A11EBA9 Q28352223-0336D7AC-CFD8-441F-9362-96E6D31207F4 Q30924135-6F2E2FCF-957E-4957-B519-ED76DD977C12 Q33583006-56F53A8C-1540-461D-B69A-3B0419CCC1C2 Q33728732-08B545AB-B8C0-4015-A7EF-7E3890D3612D Q33735405-8F7E34CB-9878-4CD5-B3FC-BAC593B30333 Q33824509-C55AEC87-E978-4937-B69F-C4A39FA351DE Q33946887-13363AFA-49E6-450D-99C3-BE2C47B0EEA4 Q34420689-EFF31160-24D7-4251-864F-899E4446FC13 Q34456265-4230CF1A-7677-48EF-9D66-B790B2C29156 Q34485306-AACA3DF6-B7C0-4623-8994-76EB90D6BBC7 Q34558516-1D240680-B7C4-4BD3-9642-BB6F2244E094 Q34573607-C3602B1D-6067-4333-BE41-95FBD69B8865 Q34602085-EE6C82C0-8DD1-4503-935B-4EC96E448490 Q34606838-9ED410F9-0070-4F04-B113-A8929A36244C Q35669997-BF9ACEFA-6EDF-4604-A829-15E4A922BCD5 Q35784044-C799C4B0-591A-4DF4-847F-121489FBECAC Q36055428-65D3F5C4-893A-4B9C-94E4-9EFE5F522DC8 Q36056818-0659D9C2-149E-47B5-9C74-5CB23EE5B055 Q36151369-9CEA2A21-5B1B-45EC-A90B-18C8BE7A42FC Q36403889-5DCFEC20-AB8A-40C0-BFA7-5F119B659269 Q36929817-ECACD37F-7614-4DE7-9DA8-DCB55677FE06 Q37283665-3313C812-F400-45F8-AB49-6EF8514429C1 Q37346995-BABF5A32-B3F2-45E8-B1C5-F91F9806D0C8 Q37386521-1533FA95-40E8-453C-8BF5-F50D307A3A04 Q37468244-C7483529-E5BF-41BC-A81B-E562B6843708 Q37596278-C611859B-DE1A-4CF4-9546-444177AEE87D Q37605350-0BC67AD9-72D9-4F3C-B8E0-60840344E248 Q37663562-68D5D153-AFC5-4738-8044-7D93A6411638 Q37706615-69DA53B2-2564-4B87-8A6D-4584D2B86A69 Q37854293-8BC2322F-CE5F-43CC-BE2C-255837AA9222 Q37858519-5D9EF634-CD63-4AF6-9BF2-CA2DBFCDCEA0 Q37895130-FBF09979-94EF-4F82-8CC7-9E247B64FD03 Q38012664-ECA97B61-D586-459A-BE94-CD2DE5D50582 Q38093664-4C605703-FF72-4B60-82A2-8BAF0B54CE38 Q38112117-70AF2822-A60C-4593-8EEC-6A611486B94D

P2860

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial.

http://www.wikidata.org/entity/Q39510239

description

1991 nî lūn-bûn

@nan

1991年の論文

@ja

1991年論文

@yue

1991年論文

@zh-hant

1991年論文

@zh-hk

1991年論文

@zh-mo

1991年論文

@zh-tw

1991年论文

@wuu

1991年论文

@zh

1991年论文

@zh-cn

name

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial.

@en

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial.

@nl

type

label

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial.

@en

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial.

@nl

prefLabel

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial.

@en

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial.

@nl

P1433

Q39510239-F7F6B4C8-5BC6-4C05-B90D-F1050E46922B

P1476

Q39510239-CFEDF878-F795-4FA3-B946-C8FBEE340C08

P2093

Q39510239-514A80C5-F8BD-4EF9-9E8D-78FE61EBF40B

Q39510239-6A321823-CAB7-47A0-B59F-C4A2E565DA4F

Q39510239-AAAC5BB2-6A1D-45A7-8285-265AB53155A2

Q39510239-B3099CB8-C835-4671-B7A6-EDD4F83E440B

Q39510239-B3EFED4B-311D-4D9B-94CF-D44019B24B56

Q39510239-DFCFFB14-7BF5-4D58-BDA3-8AE4835212F4

Q39510239-E9F971E1-6D8A-481A-BBE7-64A1F2317276

P304

Q39510239-FC698B56-8CE3-4651-AF5C-A3942825104F

P31

Q39510239-1CC83C73-078B-41C9-B218-8FE503E4DCCF

P356

Q39510239-5EAAED87-C0BC-46C0-806C-498A7AE3060C

P407

Q39510239-BA320BEA-F258-41EB-ACEA-B2192D99C0A6

P433

Q39510239-41D0CAFF-6808-4CEA-85DD-EA21A0DF0B48

P478

Q39510239-0FE50D9E-6A76-4B70-BA85-A36917860258

P577

Q39510239-D4D85A95-AA07-42F9-8B68-4087BB77F958

P698

Q39510239-81625A8F-9D63-4CBF-8BBC-6A21DB7C5690

P921

Q39510239-4971F916-FA98-4B5A-9103-219EE5326991

P356

0304-3959(91)90157-S

P1433

P1476

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial.

@en

P2093

Dubner R

http://www.w3.org/2001/XMLSchema#string

Gracely RH

http://www.w3.org/2001/XMLSchema#string

Kishore-Kumar R

http://www.w3.org/2001/XMLSchema#string

Max MB

http://www.w3.org/2001/XMLSchema#string

Meister B

http://www.w3.org/2001/XMLSchema#string

Schafer SC

http://www.w3.org/2001/XMLSchema#string

Smoller B

http://www.w3.org/2001/XMLSchema#string

P304

3-9; discussion 1-2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/0304-3959(91)90157-S

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

1991-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1861872

http://www.w3.org/2001/XMLSchema#string

P921